COLL - Collegium Pharmaceutical Inc. (COLL) CEO Joe Ciaffoni on Q4 2020 Results - Earnings Call Transcript

Collegium Pharmaceutical, Inc. (COLL) Q4 2020 Earnings Conference Call February 25, 2021 4:30 PM ET Company Participants Alex Dasalla - Head of Investor Relations Joe Ciaffoni - Chief Executive Officer Paul Brannelly - Chief Financial Officer Scott Dreyer - Chief Commercial Officer Conference Call Participants David Amsellem - Piper Jaffray Lachlan Hanbury-Brown - William Blair Serge Belanger - Needham & Company Brandon Folkes - Cantor Fitzgerald Kevin Kedra - G. Research Presentation Operator Greetings, and welcome to the Collegium Pharmaceutical Fourth Quarter 2020 Earnings Call. [Operator Instructions] As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Alex Dasalla, Head of Investor Relations for Collegium. Thank you, Ms. Dasalla. You may begin. Alex Dasalla Welcome to Collegium Pharmaceuticals fourth quarter 2020 earnings conference call. This is Alex Dasalla, Head of Investor Relations for Collegium. I am joined today by Joe Ciaffoni, our Chief

For further details see:

Collegium Pharmaceutical, Inc. (COLL) CEO Joe Ciaffoni on Q4 2020 Results - Earnings Call Transcript